Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, Cullinan Therapeutics Inc’s stock clocked out at $29.35, up 3.35% from its previous closing price of $28.40. In other words, the price has increased by $3.35 from its previous closing price. On the day, 0.87 million shares were traded. CGEM stock price reached its highest trading level at $30.1886 during the session, while it also had its lowest trading level at $27.93.
Ratios:
To gain a deeper understanding of CGEM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.07 and its Current Ratio is at 17.07. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on May 01, 2024, initiated with a Buy rating and assigned the stock a target price of $40.
On February 15, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $30.Wedbush initiated its Outperform rating on February 15, 2024, with a $30 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 01 ’24 when Savill Corrine sold 40,000 shares for $16.18 per share. The transaction valued at 647,200 led to the insider holds 165,990 shares of the business.
Savill Corrine sold 40,000 shares of CGEM for $563,600 on Jan 29 ’24. The Chief Business Officer now owns 165,990 shares after completing the transaction at $14.09 per share. On Jan 23 ’24, another insider, Savill Corrine, who serves as the Chief Business Officer of the company, sold 21,316 shares for $12.46 each. As a result, the insider received 265,597 and left with 165,990 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEM now has a Market Capitalization of 1263975424 and an Enterprise Value of 800691712.
Stock Price History:
Over the past 52 weeks, CGEM has reached a high of $29.25, while it has fallen to a 52-week low of $7.64. The 50-Day Moving Average of the stock is 58.27%, while the 200-Day Moving Average is calculated to be 131.59%.
Shares Statistics:
It appears that CGEM traded 700.10K shares on average per day over the past three months and 1673210 shares per day over the past ten days. A total of 42.90M shares are outstanding, with a floating share count of 23.06M. Insiders hold about 46.45% of the company’s shares, while institutions hold 56.05% stake in the company. Shares short for CGEM as of 1713139200 were 1678317 with a Short Ratio of 2.40, compared to 1710460800 on 935407. Therefore, it implies a Short% of Shares Outstanding of 1678317 and a Short% of Float of 4.79.
